
Paula Videira
@quintelavideira
ID: 1304922750461661184
12-09-2020 23:20:10
46 Tweet
45 Followers
27 Following

With great honor and pleasure, we presented our various lines of research in the Glupor14. It was also a delight to kick off the Glycotwinning project, of which our group leader is one of the co-coordinators. UCIBIO Faculdade de Ciências e Tecnologia | NOVA FCT World CDG Organization ProDGNE


With great honor and pleasure, we presented our various lines of research in the Glupor14. UCIBIO Faculdade de Ciências e Tecnologia | NOVA FCT World CDG Organization ProDGNE




Seeking a talented PhD researcher to join our team and contribute to our research project on pancreatic cancer. Our focus is on decoding and manipulating the immune response to sialyated O-glycans. Interested? Learn more: euraxess.ec.europa.eu/jobs/79884 #postdocs #academicjobs #stemjobs



What a fantastic week at Eurocarb21, meeting old and making new friends. The GlycoImmunology Lab work in a Keynote lecture.

GLYCOTwinning – Eurocarb 21 eurocarb2023.com/glycotw-worksh… via Eurocarb21 is tomorrow!


Uau! Reflecting on a super productive summer with #ProDGNE, engaging in insightful conversations about #GNEMyopathy! We are grateful to Lochmüller Lab for hosting our dynamic internal #ProDGNEmeeting2023 in Ottawa and grateful to all Consortium colleagues.

👏Many congratulations from all of us to Paula Videira for this achievement and for presenting and leading the work of GlycoImmunology Lab in ProDGNE!



We are excited that Dr. Paula Videira (Paula Videira), Co-Founder at CellmAbs Associate Professor & Lead at FCT-NOVA School of Science and Technology will be a keynote speaker at #CGS2024 Early bird registration until April 26, 2024: symposium.canadianglycomics.ca


Dr. Paula Videira (Paula Videira) will be presenting on "Glycoimmunology at the Crossroads: Impact of Sialylated Glycan Expression and Recognition in Cancer, Immunology, and Rare Diseases” Early bird registration until April 26, 2024: symposium.canadianglycomics.ca


On #WorldCancerDay, Paula Videira, leader of the GlycoImmunology Lab UCIBIO highlights key scientific advances in cancer treatment. observador.pt/opiniao/os-cas… i4HB Institute for Health and Bioeconomy Faculdade de Ciências e Tecnologia | NOVA FCT NOVA Observador #CancerResearch

